Building Your Foundation: Understanding C1r/C1s Deficiency
At a Glance
Complete C1r/C1s deficiency is a rare complement disorder that can raise the risk of serious infections and lupus-like autoimmunity. CH50 and AH50 testing, vaccination, kidney monitoring, and specialist care help guide evaluation and ongoing management.
C1r/C1s deficiency is an exceptionally rare condition that affects the very beginning of your immune system’s complement system [1]. The complement system is a group of proteins in your blood that “complement” the work of antibodies to clear out bacteria and dead cells [2].
Because this condition is so rare—with evidence drawn largely from small families and case reports—it is often misunderstood [1]. Many patients go through a “diagnostic odyssey,” spending years being treated for standard Systemic Lupus Erythematosus (SLE) or recurrent infections before a doctor thinks to check their specific complement levels [3][4].
How the C1 Complex Works
To understand this deficiency, it helps to look at the classical pathway, which is the first step in a chain reaction of immune defense. This pathway starts with the C1 complex, a structure made of three parts:
- C1q: The “sensor” that recognizes invaders or damaged cells [5].
- C1r and C1s: The “engines” (proteases) that activate the rest of the system [2].
When C1q finds a target, it activates C1r and C1s. They then go on to chop up other proteins (C4 and C2), starting a cascade that helps your body kill bacteria and “clean up” the debris of dying cells [5][6]. If you have a confirmed complete C1r or C1s deficiency, this entire cleanup and defense activation line is essentially broken from the start, though your alternative and lectin pathways remain available [7].
Two Major Reported Risks: Infections and Autoimmunity
A complete loss of C1r or C1s function generally increases your risk for two major clinical issues:
1. Increased Risk of Infection
Without a fully working classical pathway, your body struggles to fight off certain bacteria, particularly encapsulated organisms like Streptococcus pneumoniae or Neisseria meningitidis [7]. These can cause serious, invasive illnesses:
- Meningitis: Infection of the lining of the brain and spinal cord [1].
- Sepsis: A life-threatening reaction to infection in the bloodstream [3].
- Recurrent skin and respiratory infections: Such as pneumonia or abscesses, often beginning in early childhood [1].
2. Autoimmune Disease (SLE)
It may seem strange that an “underactive” immune system can cause an “overactive” autoimmune disease like Systemic Lupus Erythematosus (SLE). However, the C1 complex is responsible for clearing away “trash”—dead cells and bits of DNA [8]. If these aren’t cleared away, the immune system eventually treats them like invaders and begins attacking the body’s own tissues [9][7]. Lupus in people with this deficiency may be more likely to involve the kidneys (lupus nephritis) [1][10]. While not every person develops lupus or lupus nephritis, the risk is significantly higher.
Deficiency vs. Periodontal Ehlers-Danlos Syndrome (pEDS)
It is vital to distinguish complete C1r/C1s deficiency from a different condition called periodontal Ehlers-Danlos syndrome (pEDS). While they involve the same genes (C1R and C1S), they are biologically distinct and require formal genetic interpretation:
| Feature | Complete C1r/C1s Deficiency | Periodontal EDS (pEDS) |
|---|---|---|
| Genetics | Biallelic (you have two pathogenic copies of the gene) [1]. | Usually Heterozygous (you have one mutated copy) [11]. |
| Biology | Loss-of-Function: The engine is missing or inactive [7]. | Often involves abnormal protein behavior outside system control [12]. |
| Classical Pathway | Activity is absent or near zero (very low CH50) [1]. | Activity is often preserved, but the proteins behave abnormally [13]. |
| Main Symptoms | Serious infections and Lupus-like autoimmunity [7]. | Severe gum disease, typical tooth loss by age 20, and easy bruising [14][15]. |
Managing the Condition
Because this condition is so rare, there is no single “standard” treatment. Instead, care is tailored to your symptoms and risks:
- Vaccination: Staying up to date on vaccines against encapsulated bacteria is critical to help other parts of your immune system pick up the slack [3].
- Monitoring: Regular check-ups for lupus symptoms and kidney function can help catch autoimmune issues early [1].
- Specialist Care: Most patients should be followed by a Clinical Immunologist or Rheumatologist who understands complement disorders [3].
If you have a confirmed deficiency, your doctor will likely use a specialized test called a CH50 to measure the classical pathway’s total function, alongside an AH50 to ensure the rest of your complement system is working correctly [3][1].
Common questions in this guide
What is C1r/C1s deficiency?
What infections can happen with complete C1r/C1s deficiency?
Does C1r/C1s deficiency increase the risk of lupus?
What do CH50 and AH50 results mean?
How is C1r/C1s deficiency different from periodontal Ehlers-Danlos syndrome?
How is complete C1r/C1s deficiency managed?
Should family members be tested for a C1R or C1S variant?
Get notified when new evidence is published on complement component C1r/C1s deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report.
Kleer JS, Skattum L, Dubler D, et al.
Frontiers in immunology 2023; (14()):1257525 doi:10.3389/fimmu.2023.1257525.
PMID: 38469558 - 2
Headless C1q: a new molecular tool to decipher its collagen-like functions.
Fouët G, Bally I, Signor L, et al.
The FEBS journal 2021; (288(6)):2030-2041 doi:10.1111/febs.15543.
PMID: 32869492 - 3
Immunodeficiency: Complement disorders.
McMurray JC, Schornack BJ, Weskamp AL, et al.
Allergy and asthma proceedings 2024; (45(5)):305-309 doi:10.2500/aap.2024.45.240050.
PMID: 39294906 - 4
Functional Complement Analysis Can Predict Genetic Testing Results and Long-Term Outcome in Patients With Complement Deficiencies.
Blazina Š, Debeljak M, Košnik M, et al.
Frontiers in immunology 2018; (9()):500 doi:10.3389/fimmu.2018.00500.
PMID: 29619023 - 5
C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions.
Lu J, Kishore U
Frontiers in immunology 2017; (8()):592 doi:10.3389/fimmu.2017.00592.
PMID: 28596769 - 6
Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis.
Yeo JG, Leong J, Arkachaisri T, et al.
Cell death discovery 2016; (2()):16069 doi:10.1038/cddiscovery.2016.69.
PMID: 27648302 - 7
Complement C1s as a diagnostic marker and therapeutic target: Progress and propective.
Ye J, Yang P, Yang Y, Xia S
Frontiers in immunology 2022; (13()):1015128 doi:10.3389/fimmu.2022.1015128.
PMID: 36275687 - 8
Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway.
Macedo AC, Isaac L
Frontiers in immunology 2016; (7()):55 doi:10.3389/fimmu.2016.00055.
PMID: 26941740 - 9
C1q as a potential tolerogenic therapeutic in transplantation.
Baldwin WM, Valujskikh A, Fairchild RL
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021; (21(11)):3519-3523 doi:10.1111/ajt.16705.
PMID: 34058061 - 10
The axis of complement C1 and nucleolus in antinuclear autoimmunity.
Wu S, Chen J, Teo BHD, et al.
Frontiers in immunology 2023; (14()):1196544 doi:10.3389/fimmu.2023.1196544.
PMID: 37359557 - 11
Impact of a Heterozygous C1RR301P/WT Mutation on Collagen Metabolism and Inflammatory Response in Human Gingival Fibroblasts.
Qu C, Koskinen Holm C
Cells 2025; (14(7)) doi:10.3390/cells14070479.
PMID: 40214433 - 12
The yin and the yang of early classical pathway complement disorders.
Sullivan KE
Clinical and experimental immunology 2022; (209(2)):151-160 doi:10.1093/cei/uxac056.
PMID: 35648651 - 13
C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome.
Gröbner R, Kapferer-Seebacher I, Amberger A, et al.
Frontiers in immunology 2019; (10()):2537 doi:10.3389/fimmu.2019.02537.
PMID: 31749804 - 14
Periodontal manifestations of Ehlers-Danlos syndromes: A systematic review.
Kapferer-Seebacher I, Lundberg P, Malfait F, Zschocke J
Journal of clinical periodontology 2017; (44(11)):1088-1100 doi:10.1111/jcpe.12807.
PMID: 28836281 - 15
Prospective clinical investigations of children with periodontal Ehlers-Danlos syndrome identify generalized lack of attached gingiva as a pathognomonic feature.
Kapferer-Seebacher I, Oakley-Hannibal E, Lepperdinger U, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(2)):316-322 doi:10.1038/s41436-020-00985-y.
PMID: 33005042
This page explains C1r/C1s deficiency, its infection and lupus risks, and common tests for educational purposes only; it does not replace medical advice from your clinical immunologist or rheumatologist.